Curestack

Tampa, Florida, USA
VISIT WEBSITE
Curestack is a specialized real-world data (RWD) and artificial intelligence company that provides advanced infrastructure for pharmaceutical and biotechnology evidence generation. The company's core platform is designed to automate the transformation of raw clinical records into analysis-ready, regulatory-grade data, specifically addressing the complex evidence demands of global health technology assessments (HTA) and regulatory submissions. Led by industry veterans from Novartis and AveXis, Curestack focuses on high-complexity therapeutic areas such as gene therapy, oncology, and rare diseases. The company positions itself as a strategic technology partner that bridges the gap between patient-level healthcare data and the rigorous requirements of agencies like the FDA and EMA, as well as evolving HTA frameworks like the EU's Joint Clinical Assessment (JCA).
CLASSIFICATION
Company Type:Digital Health
Industry:Digital Health
Sub-Industry:HEOR & Real-World Evidence (RWE) Platforms
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M (Estimated)
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Private Angel Investors, Founder-led
PIPELINE
Stage:Commercial
Lead Drug Stage:Not a drug developer
Modalities:Digital Health Platform, RWE Analytics, AI/ML Data Engineering
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Affiliated with Komar Pharmaceuticals
Key Partnerships:Nested Knowledge (Strategic partnership for end-to-end evidence synthesis), ACCESS Forum (Scientific leadership and market access collaboration)
COMPETITION
Position:Emerging
Competitors:Aetion, Flatiron Health, Cytel, Holmusk, Tempus
LEADERSHIP
Key Executives:
Omar Dabbous, MD, MPH - Founder & CEO
Kome Okposo, PharmD - Chief Scientific Officer
Scientific Founders:Omar Dabbous, MD, MPH
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Curestack. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.